Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.

The global Prothrombin Complex market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Prothrombin Complex volume and value at global level, regional level and company level. From a global perspective, this report represents overall Prothrombin Complex market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Prothrombin Complex in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Prothrombin Complex manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Shire
CSL
Grifols
Octapharma
Hualan Biological
Meheco Xinxing Pharma
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others

Segment by Application
Hemophilia B
Vitamin K Deficiency
Others